4.6 Article

The structure of a doripenem-bound OXA-51 class D β-lactamase variant with enhanced carbapenemase activity

期刊

PROTEIN SCIENCE
卷 25, 期 12, 页码 2152-2163

出版社

WILEY-BLACKWELL
DOI: 10.1002/pro.3040

关键词

carbapenem; beta-lactamase; antibiotic resistance; crystal structure

资金

  1. National Institutes of Health [1R15AI082416, R15AI094489]
  2. Grand Valley State University Ott-Stiner Fellowship in Chemistry and the Natural Sciences
  3. National Science Foundation [CNS-1228291]
  4. U.S. DOE (Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory) [DE-AC02-06CH11357]
  5. Michigan Economic Development Corporation
  6. Michigan Technology Tri-Corridor [085P1000817]

向作者/读者索取更多资源

OXA-51 is a class D beta-lactamase that is thought to be the native carbapenemase of Acinetobacter baumannii. Many variants of OXA-51 containing active site substitutions have been identified from A. baumannii isolates, and some of these substitutions increase hydrolytic activity toward carbapenem antibiotics. We have determined the high-resolution structures of apo OXA-51 and OXA-51 with one such substitution (I129L) with the carbapenem doripenem trapped in the active site as an acyl-intermediate. The structure shows that acyl-doripenem adopts an orientation very similar to carbapenem ligands observed in the active site of OXA-24/40 (doripenem) and OXA-23 (meropenem). In the OXA-51 variant/doripenem complex, the indole ring of W222 is oriented away from the doripenem binding site, thereby eliminating a clash that is predicted to occur in wildtype OXA-51. Similarly, in the OXA-51 variant complex, L129 adopts a different rotamer compared to I129 in wildtype OXA-51. This alternative position moves its side chain away from the hydroxyethyl moiety of doripenem and relieves another potential clash between the enzyme and carbapenem substrates. Molecular dynamics simulations of OXA-51 and OXA-51 I129L demonstrate that compared to isoleucine, a leucine at this position greatly favors a rotamer that accommodates the ligand. These results provide a molecular justification for how this substitution generates enhanced binding affinity for carbapenems, and therefore helps explain the prevalence of this substitution in clinical OXA-51 variants.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据